A useful name for what accumulates in the mismatch is verification debt. It is the gap between what you released and what you have demonstrated, with evidence gathered under conditions that resemble ...
PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈